Korean J Med.  2011 Jun;80(Suppl 2):S310-S313.

Dactylitis in a Patient with Psoriatic Arthritis Treated with Infliximab

Affiliations
  • 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. sungyk@hanyang.ac.kr
  • 2Department of Nuclear Medicine, Hanyang University College of Medicine, Seoul, Korea.
  • 3Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.

Abstract

Dactylitis is a hallmark feature of psoriatic arthritis. It is usually managed with non-steroidal anti-inflammatory drugs and oral corticosteroids. Some cases have been treated successfully with intravenous corticosteroids or some disease-modifying antirheumatic drugs. Recently, inflximab has been reported as an effective treatment for dactylitis that is resistant to conventional treatment. This report describes a 37-year-old man with psoriatic arthritis who had multiple dactylitis on both thumbs and great toes. He was resistant to conventional treatment but was effectively treated with infliximab. This report highlights the effectiveness of infliximab for dactylitis, and the usefulness of blood pool imaging from bone scans as a method for determining treatment response.

Keyword

Arthritis, Psoriatic; Dactylitis; Infliximab

MeSH Terms

Adrenal Cortex Hormones
Adult
Antibodies, Monoclonal
Antirheumatic Agents
Arthritis, Psoriatic
Humans
Thumb
Toes
Infliximab
Adrenal Cortex Hormones
Antibodies, Monoclonal
Antirheumatic Agents
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr